Evidence map›Paper›PMID 30971163›Full record

ArticleJournal of the American Heart Association2019

Pulse Pressure is a Stronger Predictor Than Systolic Blood Pressure for Severe Eye Diseases in Diabetes Mellitus.

Masahiko Yamamoto, Kazuya Fujihara, Masahiro Ishizawa, Taeko Osawa, Masanori Kaneko, Hajime Ishiguro, Yasuhiro Matsubayashi, Hiroyasu Seida, Nauta Yamanaka, Shiro Tanaka and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Pulse Pressure and Diabetic Eye Disease.Journal of the American Heart Association · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Masahiko Yamamoto1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Kazuya Fujihara1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Masahiro Ishizawa1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Taeko Osawa1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Masanori Kaneko1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Hajime Ishiguro1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Yasuhiro Matsubayashi1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Hiroyasu Seida2 Japan Medical Data Center Co., Ltd. Tokyo Japan.
Nauta Yamanaka2 Japan Medical Data Center Co., Ltd. Tokyo Japan.
Shiro Tanaka3 Department of Clinical Biostatistics Graduate School of Medicine Kyoto University Kyoto Japan.
Satoru Kodama1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Hiruma Hasebe4 Department of Ophthalmology Niigata University Faculty of Medicine Niigata Japan.
Hirohito Sone1 Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan.
Niigata University · JPJapan Clinical Cancer Research Organization · JPKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Evidence of the role of systolic blood pressure ( SBP ) in development of severe diabetic retinopathy is not strong, although the adverse effect of low diastolic blood pressure has been a partial explanation. We assessed the predictive ability of incident severe diabetic retinopathy between pulse pressure ( PP ) which considers both SBP and diastolic blood pressure, compared with SBP . Methods and Results Eligible patients (12 242, 83% men) aged 19 to 72 years from a nationwide claims database were analyzed for a median observational 4.8-year period. Severe diabetic retinopathy was defined as vision-threatening treatment-required diabetic eye diseases. Multivariate Cox regression analysis revealed that hazard ratios (95% CI ) of treatment-required diabetic eye diseases for 1 increment of standard deviation and the top tertile compared with the bottom tertile were 1.39 (1.21-1.60) and 1.72 (1.17-2.51), respectively, for PP and 1.22 (1.05-1.41) and 1.43 (0.97-2.11), respectively, for SBP adjusted for age, sex, body mass index, hemoglobin A1c, fasting plasma glucose, lipids, and smoking status. In a model with SBP and PP simultaneously as covariates, the hazard ratios of only PP (hazard ratios [95% CI ], 1.57 [1.26-1.96]) but not SBP (0.85 [0.68-1.07]) were statistically significant. Delong test revealed a significant difference in the area under the receiver operating characteristic curve between PP and SBP (area under the receiver operating characteristic curve [95% CI ], 0.58 [0.54-0.63] versus 0.54 [0.50-0.59]; P=0.03). The strongest predictor remained as hemoglobin A1c (area under the receiver operating characteristic curve [95% CI ], 0.80 [0.77-0.84]). Conclusions After excluding the significant impact of glycemic control, PP in comparison with SBP is a better predictor of severe diabetic retinopathy, suggesting a role of diastolic blood pressure and arterial stiffness in pathology.

Indexed as

Blood PressureAdultAgedBlood GlucoseDiabetes MellitusDiabetic RetinopathyDiastoleFemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMiddle AgedMultivariate AnalysisProportional Hazards ModelsRisk FactorsBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic Agentsblood pressurediabetic mellitushemoglobin A1cpulse pressuresystolic blood pressurevision‐threatening treatment‐required diabetic eye diseases

Identifiers

PMID30971163
PMCPMC6507184
OpenAlexW2939455690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.